Get the app
US › Financial Services

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

US · Financial Services · Shell Companies

$10.840.00%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$1.7M
Profit YoY
-24.5%
EPS
$0.06

Key statistics

Market cap
$262.2M
P/E
60.0
Forward P/E
0.0
P/B
1.90
Book value
$-0.30
EPS (TTM)
$0.18
52-week high
$10.80
52-week low
$10.23
50-day MA
$10.72
200-day MA
$10.54

Shareholding

Insiders
23.57%
Institutions
53.14%

Largest institutional holders

FundStake
Karpus Management Inc10.42%
First Trust Capital Management L.P.9.24%
Mizuho Securities USA Inc8.24%
Westchester Capital Management LLC6.87%
Polar Asset Management Partners6.59%
Wolverine Asset Management LLC6.40%
Highbridge Capital Management, LLC5.45%
Glazer Capital, LLC4.12%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Drugs Made In America Acquisition Corp. Ordinary Shares — free to start.

Google PlayApp Store

Other Financial Services companies

Berkshire Hathaway IncBerkshire Hathaway IncJPMorgan Chase & CoVisa Inc. Class AMastercard IncBank of America CorpHSBC Holdings PLC ADRMorgan StanleyGoldman Sachs Group IncRoyal Bank of CanadaWells Fargo & CompanyMitsubishi UFJ Financial Group Inc ADR

Data updated 2026-09-18.